Open access · US-GOV via ClinicalTrials.gov Clinical trial

Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease

Authors not listed

University of California, San Francisco · 2021

Loss of proteostasis Human Randomized controlled trial

Abstract

This study aimed to pilot test a non-pharmacological (behavioral) treatment program targeting improved cognition through improving 24-h sleep-wake cycle in people with mild cognitive impairment (MCI) or mild Alzheimer's disease. A treatment program incorporating bright light therapy and a modified cognitive behavioral therapy for insomnia will be developed to address 24-hour patterns of sleep. We will then pilot test its feasibility and explore its preliminary effects on improving sleep/napping and cognition in patients with MCI or mild Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-15 MST

Cite this

APA

Anonymous. (2021). Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease. <em>University of California, San Francisco</em>. https://clinicaltrials.gov/study/NCT03256539

Vancouver

Anonymous. Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease. University of California, San Francisco. 2021.

BibTeX

@misc{anon2021Nappin, title = {Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease}, author = {Anonymous}, journal = {University of California, San Francisco}, year = {2021}, }